Gene · 116844
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the complex web: pathogenesis and prevention of gestational diabetes mellitus-related fetal overgrowth. | Front Cell Dev Biol | 2026 | 41710943 | PubTator, text mining | PubMed |
| Predicting mucosal healing in patients with ulcerative colitis in clinical remission using biomarkers: A single-center prospective pilot study. | Medicine (Baltimore) | 2026 | 41686630 | PubTator, text mining | PubMed |
| Leucine-Rich α2 Glycoprotein as a Predictor of Small Bowel Disease Activity in Crohn's Disease: A Retrospective Study. | JMA J | 2026 | 41676783 | PubTator, text mining | PubMed |
| Optimization of potential targets for antidepressant Chinese medicines: AI and multi-omics methods. | Chin Med | 2026 | 41668206 | PubTator, text mining | PubMed |
| AI-driven biomarker learning for the early diagnosis of neurodegenerative diseases: ABLEDx. | J Nanobiotechnology | 2026 | 41654846 | PubTator, text mining | PubMed |
| Uncovering urinary proteogenomic signatures associated with head and neck squamous cell carcinoma. | Mol Omics | 2026 | 41649151 | PubTator, text mining | PubMed |
| Cancer drives atherosclerotic plaque vulnerability by inducing pathological angiogenesis. | bioRxiv | 2026 | 41648335 | PubTator, text mining | PubMed |
| Role of leucine-rich α-2-glycoprotein in Taiwanese patients with inflammatory bowel disease as a predictive biomarker for endoscopic activity. | World J Gastroenterol | 2026 | 41640607 | PubTator, text mining | PubMed |
| Leucine-rich alpha-2 glycoprotein as a blood biomarker in inflammatory bowel disease: clinical implications and future perspectives. | Expert Rev Gastroenterol Hepatol | 2026 | 41636455 | PubTator, text mining | PubMed |
| Exploring potential biomarkers of NETosis-Related genes in spinal cord injury through machine learning and multi-omics analysis. | Biochem Biophys Rep | 2026 | 41625596 | PubTator, text mining | PubMed |
| Plasma Proteomic Profile of Chemotherapy-Induced Severe Neutropenia: A Pilot Discovery Phase Study. | FASEB J | 2026 | 41622794 | PubTator, text mining | PubMed |
| Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer. | Oncol Res Treat | 2026 | 41610070 | PubTator, text mining | PubMed |
| Functional Molecular Plasma Biomarkers of Inflammation and Repair in Kidney Disease Progression in Gum Arabica Modality of CKD. | Int J Mol Sci | 2026 | 41596619 | PubTator, text mining | PubMed |
| Risk prediction models for detecting a new diagnosis of heart failure within 5 years in the community: a systematic review. | BMJ Open | 2026 | 41565332 | PubTator, text mining | PubMed |
| Epigenetic age and neurodevelopmental outcomes in children born preterm. | Genet Med Open | 2026 | 41551007 | PubTator, text mining | PubMed |
| Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analysis. | Transl Oncol | 2026 | 41547146 | PubTator, text mining | PubMed |
| Investigating the mechanism of berberine in inhibiting periodontitis progression using machine learning, molecular docking, and experimental validation. | Arch Oral Biol | 2026 | 41544413 | PubTator, text mining | PubMed |
| Investigating the Role of LRG1 in Hepatosteatosis and Insulin Resistance in Obese Children | J Clin Res Pediatr Endocrinol | 2026 | 41521682 | PubTator, text mining | PubMed |
| The serum level of leucine-rich alpha-2 glycoprotein to differentiate between ischemic and non-ischemic retinal vein occlusion. | Photodiagnosis Photodyn Ther | 2026 | 41519419 | PubTator, text mining | PubMed |
| Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein Levels in Inflammatory Bowel Disease Patients across Racial Groups. | Inflamm Intest Dis | 2026 | 41446437 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/116844/papers?page=4